On 24 July 2015, the Court of Arbitration for Sport (CAS) issued an Interim Award in the arbitration procedure between the Indian athlete Dutee Chand, the Athletics Federation of India (AFI) and the International Association of Athletics Federations (IAAF). The CAS Panel in charge of the procedure (The Hon. Justice Annabelle Claire Bennett AO, Australia (President), Prof. Richard H. McLaren, Canada, and Dr Hans Nater, Switzerland) suspended the “IAAF Regulation Governing Eligibility of Females with Hyperandrogenism to Compete in Women’s Competition” (the “Hyperandrogenism Regulations”) until 24 July 2017 in order to give the IAAF the opportunity to provide the CAS with scientific evidence about the quantitative relationship between enhanced testosterone levels and improved athletic performance in hyperandrogenic athletes.

Based upon the agreement of the parties and at the approval of the Panel, the Hyperandrogenism Regulations have been suspended for an additional two (2) months. During such extended suspension, Ms Dutee Chand remains eligible to compete in both national and international level athletics events. Should the IAAF not file any scientific evidence within the additional two-month period granted by the CAS Panel (i.e. end of September 2017), the Hyperandrogenism Regulations will be declared void.

• This media release was originally published by the Court of Arbitration for Sport (CAS) on 28 July 2017. To access the original, please click here.